Neuroene Therapeutics Inc.

Kensington, MD

UEI
FE9HTJ2TLGY5
CAGE
7EGQ1
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Woman Owned Business
  • Asian-Pacific American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3 Torrance Ct, Kensington, MD 20895, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
A vitamin k analog countermeasure for organophosphate poisoning R43AI176434 National Institute of Allergy and Infectious Diseases (NIH) $896,307
Development of new anti-epilepsy treatments targeting cellular energetics through mitochondrial modulation with optimal… R44NS097047 National Institute of Neurological Disorders and Stroke (NIH) $1,561,437
Novel mechanism for the treatment of epilepsy: new vitamin k analogs target energetics and have low toxicity due to… R41NS097047 National Institutes of Health $224,803

Quick answers

Is Neuroene Therapeutics Inc. registered in SAM.gov?

Yes. Neuroene Therapeutics Inc.'s SAM.gov registration is active through February 9, 2027.

What is Neuroene Therapeutics Inc.'s most recent federal award?

Neuroene Therapeutics Inc.'s most recent federal grant award is A vitamin k analog countermeasure for organophosphate poisoning (R43AI176434), from National Institute of Allergy and Infectious Diseases (NIH), on May 18, 2023.

On GovTribe

See Neuroene Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login